Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Rick Doblin, Ph.D.,
Cannabis Law Report
JUNE 11, 2019
While there is anecdotal evidence that CBD does have beneficial properties, I heard no evidence that that claim has been established through recognized clinical trials. Robichaud , 2007 NBQB 50. Raj , 2013 BCSC 308. In rejecting the claim, the court cited Torchia v. Siegrist with approval. ” 42. Footnotes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 24, 2021
Authors of texts may use more surreptitious, and sometimes unconscious, literary devices such as rhetoric, trope, metaphor, or juxtaposition—techniques that evoke moral positions, predictions of possible effects, and prescribe solutions (Entman 1993 ; Johnson-Cartee 2005 ; Weaver 2007 ). MJA, 16 December 2013).
Cannabis Law Report
OCTOBER 29, 2019
Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2013 Sep;36(9):2530-5.
Expert insights. Personalized for you.
52 
Let's personalize your content